Sanford (Sandy) Dawsey, MD
Dr. Dawsey recentlyretired as a Senior Investigator at the National Cancer Institute of theNational Institutes of Health, where he worked for 36 years. During his time atNIH, his main focus was the prevention and control of esophageal squamous cellcarcinoma (ESCC). He performed multiplestudies in China, Iran, Brazil and East Africa to understand the etiology ofthis cancer globally in high-risk populations, and he helped develop clinicallyuseful early detection and treatment techniques for this disease. With US andChinese colleagues, he developed an endoscopic early detection and treatmentprogram for esophageal squamous cell carcinoma that is now used in a nationalprogram to screen over 200,000 adults annually in high-risk areas of China, andthis program has been shown to reduce ESCC mortality by ~33% over 10 years.Most recently, he was a founding member of the African Esophageal CancerConsortium (AfrECC), which was created to perform coordinated etiologic, earlydetection and treatment, and palliation studies to try to reduce the burden ofESCC in Africa. He is currently President of the Board of the AfricanEsophageal Cancer Consortium Foundation.
